Selective derivatization of single hydroxyl groups within frameworks containing several is a long-standing challenge in synthetic chemistry.[@R1] Work in our group has examined a variety of asymmetric group transfer reactions of alcohols (e.g., acylation,[@R2],[@R3] phosphorylation,[@R4] sulfinylation,[@R5] thiocarbonylation[@R6]) predicated on putative nucleophilic catalysis by histidine-containing peptides ([Figure 1](#F1){ref-type="fig"}). This concept has proven surprisingly general, furnishing additional powerful new methods and catalysts.[@R7],[@R8] This strategy is at the heart of one approach to the systematic modification of complex polyol structures, such as those found in complex antibiotics like erythromycin A. Using this tactic, one can employ a unique catalyst library type, along with a range of electrophiles, to produce a set of natural product-derived analogs for biological evaluation.[@R9],[@R10] In order to expand the repertoire of analogs that can be accessed and to increase the general utility of these group transfer processes in organic synthesis, the addition of novel electrophiles is a consistent goal of this work. One underdeveloped sub-field in this area is the asymmetric transfer of sulfur-based electrophiles. Asymmetric sulfinylation may be the best-studied sub-class of S-group transfer.[@R11],[@R12] Yet, despite the widespread use of sulfonates in complex molecule synthesis, approaches to asymmetric catalytic sulfonate transfer are rare.[@R13],[@R14],[@R15] Herein, we report a tetrapeptide catalyst for the desymmetrization of select *meso*-1,3-diols through a direct enantioselective monosulfonylation reaction. Notably, the lead catalyst bears strong stereochemical analogy to scaffolds previously found to be effective for orthogonal group transfer reactions. Yet, detailed studies of the stereochemical aspects of these two group transfer processes (S-electrophile versus P-electrophile) reveal opposite enantioselectivties from a common catalyst scaffold for these processes.[@R16] Stereochemical divergence among related catalysts for orthogonal group transfers may reveal an as yet underappreciated mechanistic nuance for histidine-dependent catalysts. Moreover, from the functional point of view, these observations expand the utility of complementary group transfer processes, allowing access to complementary stereoisomeric products from a common catalyst scaffold.

Results {#S1}
=======

To achieve catalytic enantioselective synthesis of sulfonate esters by sulfonyl transfer, we chose 2,4,6-tribenzyl-*myo*-inositol (**1**) as a test-substrate and *p*-nitrobenzenesulfonyl chloride (*p-*NsCl) as the sulfonylating agent ([Table 1](#T1){ref-type="table"}). Derivatives of *myo*-inositol have proven valuable in earlier studies of enantioselective group transfer, in particular for analogous transfers of phosphorous(V)-based reagents such as diphenylphosphoryl chloride.[@R17] *myo*-Inositol derivative **1** presents the challenge of desymmetrization of the enantiotopic hydroxyl groups at the 1- and 3-positions, as well as the free hydroxyl group at the 5-position, along the mirror plane of the substrate. As hindered amine bases are often sufficient to promote the sulfonylation of alcohols in the absence of any catalyst, insoluble inorganic bases were first evaluated as the stoichiometric base. Among the bases screened (including MgO, K~2~CO~3~, and Na~2~CO~3~), NaHCO~3~ was identified as the optimal base, providing no observable sulfonate product in the absence of catalyst at 23 °C in 24 h, and good conversions in the presence of *N*-methyl imidazole (NMI) or peptide catalyst.

With appropriate conditions established, a series of π-methyl-histidine (Pmh)-containing peptides were evaluated based on their ability to influence the enantioselectivity of the reaction ([Table 1](#T1){ref-type="table"}). Catalyst screening began with peptide **3** due to its high enantiocontrol in the phosphorylation of inositol substrate **1**.[@R4] Although the enantiomer ratio (er) observed with peptide **3** was quite modest (67.5:32.5 er, entry 1), this result provided a starting point for catalyst optimization. Changing the amino acid in the *i*+3 position from an aromatic residue to leucine (Leu) dramatically increased the enantioselectivity to 84.5:15.5 er (catalyst **4**, entry 2). The *tert*-butoxy group of the L-hydroxy proline (Hyp) residue was found to be important for high er's as replacement with L-proline (Pro) resulted in a significant decrease in enantioselectivity (entry 3 vs. 4). The impact of the *i*+2 position on enantioselectivity was probed through the use of *gem*-disubstituted amino acids, L-valine (Val), and D-valine (D-Val) (entries 5--8). The use of 1-amino-isobutyric acid (Aib) resulted in a small decrease in enantioselectivity compared to the five-membered spirocyclic residue (Sp5). Incorporation of a D-amino acid improved the enantioselectivity (92.5:7.5 er, entry 7) while a L-amino acid led to reduced enantioselectivity (60.0:40.0 er, entry 8). It is possible that these changes influence β-turn stability.[@R18] The stereochemistry of the *i*+4 position was also probed through the use of D-Phe (catalyst **9**). This catalyst resulted in a more selective reaction than the analogous L-Phe peptide (91.5:8.5 er for catalyst **9**, and 89.0:11.0 er for catalyst **4**). The small degree of influence, however, suggested that the peptide could be truncated and still retain its high enantioselectivity. In fact, tetrapeptide **10**, showed the highest enantioselectivity to date (97.0:3.0 er, entry 10).

In addition to *p*-NsCl, a variety of other sulfonylating agents were assayed using catalyst **10** and triol **1** as the substrate ([Figure 2](#F2){ref-type="fig"}). Usage of *ortho*-nitrosulfonyl chloride led to reduced enantioselectivity (97.0:3.0 er for **2a** vs. 66.0:34.0 er for **2b**) suggesting the reaction is sensitive to the steric effects. Nitro-substitution in the 3-position was less consequential (**2c**, 95.5:4.5 er). Additionally, the er of the reaction was found to be sensitive to the electronic properties of the arenesulfonyl chloride, with electron donating groups having a detrimental effect on enantioselectivity (**2d** is formed with an 85.5:14.5 er; **2e**, 77.5:22.5 er).

Concurrent with catalyst and sulfonylation agent optimization, other reaction parameters were explored to maximize rate and enantioselectivity. A variety of solvents were evaluated, but none proved superior to CH~2~Cl~2~. To further increase rates, catalyst **10** was evaluated at 23 °C. Indeed, faster rates were observed, but the er was smaller (92.0:8.0). While high enantioselectivity was consistently observed when solid NaHCO~3~ was used as the base, the reaction rates were slow and inconsistent yields (25--75%) were recorded. As a result, two new sets of conditions were identified that furnish consistently good yields of **2a** in shorter reaction times: condition **A** uses a biphasic system of saturated NaHCO~3~ (aq)/CH~2~Cl~2~ (1:2 v/v) to produce (mono)sulfonate **2a** in 76% yield and 97.0:3.0 er;[@R19] condition **B** uses 2,6-lutidine in CH~2~Cl~2~ to give **2a** in 66% yield and 95.0:5.0 er ([Table 2](#T2){ref-type="table"}, entry 1).

The rapid identification of a catalyst for the desymmetrization of **1** bodes extremely well for the identification of highly effective catalysts for enantioselective sulfonylation of broad and diverse structural types.[@R20],[@R21] Moreover, the studies above establish simple tetrapeptide catalysts as fertile ground for study of a variety of stereochemical arrays. For studies of polyol modification, catalyst "generality" is much less significant than catalyst library "diversity." Neverthless, given the simplicity of catalyst **10**, and the highly practical nature of conditions **A** and **B**, we asked whether or not the processes identified for substrate **1** might be applicable to others. Notably, both conditions **A** and **B** enable desymmetrization of a number of other 1,3-diols ([Table 2](#T2){ref-type="table"}). In general, the biphasic conditions (**A**) provide higher yields and enantioselectivities. For example, the benzyl protecting groups can be exchanged for *p*-methoxy benzyl groups without loss of enantioselectivity (entry 2). Additionally, the reaction is tolerant of quite dramatic modifications of the 5-position of inositol (entries 3--6). Small changes at the 2-position of inositol lead to some decrease in enantioselectivity (88.0:12.0 er, entry 7). Furthermore, while *cis*-1,3-cyclohexane diol shows good reactivity, the reaction is not enantioselective (entry 8). We believe that condition A gives a low yield of product due to the high water solubility of the starting material. Interestingly, the acyclic 1,3-diol derived from adonitol (**19**) shows high enantioselectivity (89.0:11.0 er) and good reactivity (entry 9), while all-*syn* stereoisomer **20** reacts slowly and with depreciated enantioselectivity (62.0:38.0 er; entry 10).

From a mechanistic point of view, the observed desymmetrizations appear to be a result of enantiotopic group selection, rather than secondary kinetic resolution of the monofunctionalized product.[@R22] As shown in [Figure 3](#F3){ref-type="fig"}, when peptide **10** was evaluated for kinetic resolution of racemic (±)-**2a**, the starting material was recovered (60% mass recovery) with only 57.0:43.0 er (*k*~rel~ = 1.7).

These initial mechanistic studies set the stage for a rather remarkable observation. The determination of the absolute configuration of the products derived from the mono(sulfonylation) reveals a stark contrast between peptide-catalyzed asymmetric sulfonylations and the equivalent peptide-catalyzed phosphorylations. We have shown on a number of occasions a strong correlation between the secondary structure of a given enantioselective histidine-based catalyst and the absolute sense of chirality transfer for various electrophiles. For example, we have shown that the enantioselectivity of acylation reactions mediated by diastereomeric peptides was strongly dependent on the type of β--turn nucleated by either a D-Proline residue or an L-Proline residue in the catalyst ([Figure 4](#F4){ref-type="fig"}).[@R18],[@R23] Analogous observations consistently appear throughout our studies of asymmetric phosphorylation.[@R17]

On the other hand, we had not systematically compared the absolute sense of induction provided by related peptide-based catalysts when challenged with different electrophiles. In fact, naïvely, we had often assumed that although the mechanisms of acyl transfer, phosphoryl transfer and other group transfers were clearly nuanced and different, the details of catalyst-substrate recognition could likely be analogous, and the absolute senses of asymmetric induction would also be the same in most cases. Thus, in order to evaluate this issue, we synthesized the mono(nosylated), mono(phosphorylated) inositol **25** through two independent methods ([Figure 5](#F5){ref-type="fig"}) and compared their HPLC retention times. From previous work, it is known that peptide **3** phosphorylates **1** with high levels of enantioselectivity (\>99:1 er) at the 3-position of inositol to provide **24**.[@R17] Upon mono(sulfonylation) with an achiral catalyst, **25** was then obtained. However, mono(sulfonate) **2a**, obtained from reaction with peptide **10** (97.0:3.0 er), was then subjected to phosphorylation and surprisingly also gave compound **25**. It should be noted that neither **24** nor **2a** racemize under the sulfonylation or phosphorylation conditions. On the other hand, selective phosphorylation at the 1-position of **1**,[@R4] followed by nosylation gives the opposite enantiomer. *Thus, peptides* ***3*** *and* ***10****, which possess superficially similar peptide sequences, catalyze bond-forming reactions at enantiotopic hydroxyl groups when subjected to either phosphorylation or sulfonylation conditions, respectively.* These results suggest disparate details of catalyst-substrate recognition in the respective group transfer reactions, depending on conditions and the nature of the electrophile. The mechanistic basis of these enantiodivergent reactions at present is elusive, and a myriad of mechanistic scenarios must be considered. Changes in mechanism as drastic as the difference between nucleophilic and general base catalysis represent but one possibility under consideration. Likewise, the differences in the nature of the charge distributions exhibited by various activated Lewis basic catalytic intermediates may have fundamentally different consequences for activated catalyst conformations.[@R24] Elucidation of these mechanistic nuances requires extensive physical organic studies, and these are underway in our laboratory.

The significance of these observations is both methodological and fundamental. On the one hand, these results expand the scope of asymmetric peptide-catalyzed group transfer reactions to include an important class of S-based electrophiles. The substrate scope exhibited by even a single catalyst is encouraging as expanded catalyst libraries may now be applied to more complex substrates with the goal of achieving disparate sites of reaction for the realization of analogs. In addition, our new findings point to intriguing mechanistic nuances when different electrophiles are employed. The notion that a unique amino acid side chain may exhibit distinct and unusual roles is well precedented in enzymes, in particular when diverse reactions are carried out by different enzymes. For example, the active site histidine in various histidine-dependent kinases is often demonstrated to serve as a catalytic nucleophile.[@R25] On the other hand, in lipases and proteases the active site histidines more often serve the role of a general base.[@R26] While our experiments in no way imply so drastic a change in mechanism, the reversal of enantioselectivity in two superficially similar reactions support very different transition states for the two enantiomer determining steps. Highly selective catalysts that bear structural similarity, but exhibit their catalytic prowess by different mechanisms have been viewed by some as a hallmark of privileged catalysts in nature,[@R27] or the laboratory.[@R28] We hope to learn more about these issues as we pursue methodological goals with this intriguing family of peptide-based catalysts in parallel.

Methods {#S2}
=======

General procedure for sulfonylation using condition A ([Table 2](#T2){ref-type="table"}) {#S3}
----------------------------------------------------------------------------------------

To an oven-dried 1 dram vial equipped with a magnetic stir bar was added diol substrate (0.10 mmol) and CH~2~Cl~2~ (0.4 mL). The peptide catalyst **10** (3.4 mg, 0.005 mmol) was then added and the reaction was cooled to 0 °C. 4-Nitrobenzenesulfonyl chloride (28.8 mg, 0.13 mmol) was added followed by 0.2 mL sat. aq. NaHCO~3~ solution. The reaction was monitored by TLC for the disappearance of the sulfonyl chloride and allowed to stir at 0 °C for 5--48 h. The biphasic reaction mixture was diluted with CH~2~Cl~2~ (2 mL) and sat. aq. NaHCO~3~, and the layers were separated. The aqueous layer was extracted with CH~2~Cl~2~ (2 × 2 mL). The combined organic layers were dried over Na~2~SO~4~, filtered, and concentrated under reduced pressure. The resulting yellow oil was purified by silica gel flash chromatography.

General procedure for sulfonylation using condition B ([Table 2](#T2){ref-type="table"}) {#S4}
----------------------------------------------------------------------------------------

To an oven-dried 1 dram vial equipped with a magnetic stir bar was added diol substrate (0.10 mmol) and CH~2~Cl~2~ (0.4 mL). The peptide catalyst **10** (3.4 mg, 0.005 mmol) was then added and the reaction was cooled to 0 °C. 4-Nitrobenzenesulfonyl chloride (28.8 mg, 0.13 mmol) was added followed by 2,6-lutidine (17.5 μL, 0.15 mmol). The reaction was monitored by TLC for the disappearance of the sulfonyl chloride and allowed to stir at 0 °C for 5--48 h. The reaction mixture was diluted with CH~2~Cl~2~ (2 mL), and 1M HCl (0.5 mL) was added. The layers were separated, and the aqueous layer was extracted with CH~2~Cl~2~ (2 × 2 mL). The combined organic layers were dried over Na~2~SO~4~, filtered, and concentrated under reduced pressure. The resulting yellow oil was purified by silica gel flash chromatography.
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![π-Methyl-histidine-containing peptides for group transfer chemistry\
Previous work from the Miller group has resulted in selective transfer of acyl, phosphoryl, sulfinyl, and thiocarbonyl groups to alcohols using π-methyl-histidine-containing peptides. These reactions are thought to proceed through a *N*-methyl imidazolium intermediate generated by nucleophilic attack of the imidazole moiety on the electrophile. Careful design and optimization of the peptide catalysts can allow for the facile synthesis of a variety of analogs of complex polyols.](nihms145800f1){#F1}

![The influence of the arene-sulfonyl chloride on the enantioselectivity and yield\
The reactions were run using various substituted arene-sulfonyl chlorides. Yields were low for all reactions except when *p*-nitrobenzenesulfonyl chloride was used (product **2a**). Moving the nitro group to the *meta*-position had little effect on the enantiomer ratio (er) of the product, while moving the nitro group in the *ortho*-position dramatically decreased the er of the products. Additionally, a slight decrease in er of the products was observed when electron-rich *para*-substituents were used (X = *p*-Me or *p*-MeO, **2d** and **2e**, respectively).](nihms145800f2){#F2}

![Kinetic resolution of racemic mono(sulfonate) 2a\
Mono(sulfonate) **2a** was prepared in racemic form and subjected to the reaction conditions. After 40% conversion to the bis(nosylate) **21**, the starting material was recovered with 57:43 er, corresponding to a relative rate constant ratio of the fast enantiomer to the slow enantiomer (k~rel~) of 1.7. This low k~rel~ indicates that the high enantioselectivity observed for the desymmetrization of inositol-based 1,3-diols is primarily the result of enantiotopic group selection rather than kinetic resolution of the monofunctionalized product.](nihms145800f3){#F3}

![Chirality of proline determines the absolute sense of asymmetric induction\
In previous work in the Miller group, the enantioselectivity of acylation reactions mediated by diastereomeric peptides was strongly dependent on whether the -turn of the peptide catalyst was nucleated by a D-Proline residue or an L-Proline residue.](nihms145800f4){#F4}

![Determination of absolute configuration of sulfonates by comparison to phosphorylation\
(Mono(nosylated), mono(phosphorylated) inositol **25** was prepared through two independent methods, and the products were compared by HPLC retention times. From previous work, it was known that peptide **3** selectively phosphorylates inositol **1** at the 3-position to give diol **24**. Sulfonylation of **24** using an achiral catalyst produces compound **25.** Surprisingly, phosphorylation of mono(sulfonate) **2a** obtained through nosylation mediated by peptide **10** also yielded **25**. Therefore, despite the similarity between peptides **3** and **10**, they act at enantiotopic alcohols for phosphorylation and sulfonylation.](nihms145800f5){#F5}
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###### 

Selected data from sulfonylation catalyst screen.[a](#TFN1){ref-type="table-fn"}

  -------- -------- ------- ---------- ------- ---------- ----------- -----------
  **1**    **3**    23 °C   Hyp(But)   Sp5     Tyr(But)   Phe         67.5:32.5
  **2**    **4**    23 °C   Hyp(But)   Sp5     Leu        Phe         84.5:15.5
  **3**    **5**    23 °C   Hyp(But)   Aib     Leu        Phe         83.5:16.5
  **4**    **6**    23 °C   Pro        Aib     Leu        Phe         76.5:23.5
  **5**    **4**    0 °C    Hyp(But)   Sp5     Leu        Phe         89.0:11.0
  **6**    **5**    0 °C    Hyp(But)   Aib     Leu        Phe         87.0:13.0
  **7**    **7**    0 °C    Hyp(But)   D-Val   Leu        Phe         92.5:7.5
  **8**    **8**    0 °C    Hyp(But)   Val     Leu        Phe         60.0:40.0
  **9**    **9**    0 °C    Hyp(But)   Sp5     Leu        D-Phe       91.5:8.5
  **10**   **10**   0 °C    Hyp(But)   Sp5     Leu        \-\-\-\--   97.0:3.0
  **11**   **11**   0 °C    Hyp(But)   D-Val   Leu        \-\-\-\--   95.5:4.5
  -------- -------- ------- ---------- ------- ---------- ----------- -----------

Reactions were run with 1.0 equiv 2,4,6-tribenzyl-*myo*-inositol (**1**) and 1.0 equiv 4-nitrobenzenesulfonyl chloride. Reactions were run under a common set of conditions, and conversions were found to be approximately 10%, with some variation. The issue of secondary kinetic resolution was addressed subsequently (*vide infra*).

All enantiomer ratios were measured using chiral HPLC.

###### 

Substrate scope for sulfonylation of *meso*-1,3-diols.[a](#TFN3){ref-type="table-fn"}

  ------- ----- ---------- ------- ---------- ----------- -- ------- ----- -----------
  **1**         **A**      76%     97.0:3.0   **6**          **A**   75%   96.5:3.5
  **B**   66%   95.0:5.0   **B**   56%        95.5:4.5                     
  **2**         **A**      75%     97.0:3.0   **7**          **A**   57%   88.0:12.0
  **B**   58%   95.0:5.0   **B**   42%        82.5:17.5                    
  **3**         **A**      62%     95.5:4.5   **8**          **A**   12%   50.0:50.0
  **B**   60%   95.0:5.0   **B**   61%        50.0:50.0                    
  **4**         **A**      58%     95.5:4.5   **9**          **A**   74%   89.0:11.0
  **B**   53%   91.5:8.5   **B**   65%        86.0:14.0                    
  **5**         **A**      76%     96.0:4.0   **10**         **A**   16%   62.0:38.0
  **B**   76%   94.5:5.5   **B**   40%        69.0:31.0                    
  ------- ----- ---------- ------- ---------- ----------- -- ------- ----- -----------

All reactions were run with 5 mol% peptide **10,** 1.0 equiv substrate and 1.3 equiv 4-nitrobenzenesulfonyl chloride in for 5--24 hours.

Condition **A** uses 0.2 mL sat. aq. NaHCO~3~, condition **B** uses 1.5 equiv 2,6-lutidine.

Isolated yield of mono(sulfonate), an average of at least two trials.

All enantiomer ratios were measured using chiral HPLC and are an average of at least two trials.
